June 5 (Reuters) - US Oncology Inc:
* To sell an aggregate $775 million principal amount of 9-1/8 percent senior secured notes due 2017
* Notes to be sold at 97.926 percent of their face value, plus accrued interest from June 4, 2009
* Proceeds to be used to repay $436.7 million outstanding under its existing
secured term loan credit facility
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* To sell an aggregate $775 million principal amount of 9-1/8 percent senior secured notes due 2017
* Notes to be sold at 97.926 percent of their face value, plus accrued interest from June 4, 2009
* Proceeds to be used to repay $436.7 million outstanding under its existing
secured term loan credit facility
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.